IHydrochlorothiazide

Incazelo emfushane:

Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
IHydrochlorothiazide Ama-diuretics USP/EP/CEP 16750 CEP 2006-011


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

IMINININGWANE YOMKHIQIZO

Incazelo

IHydrochlorothiazide (HCTZ), umuthi osebenza ngomlomo wesigaba se-thiazide, inqanda ukuguqula i-TGF-β/Indlela yokusayina esmad.IHydrochlorothiazide inemiphumela eqondile yokuphumuza imithambo ngokuvula isiteshi se-calcium-activated potassium (KCA).IHydrochlorothiazide ithuthukisa ukusebenza kwenhliziyo, yehlisa i-fibrosis futhi inomphumela we-antihypertensive.

Ingemuva

IHydrochlorothiazide iyisidakamizwa se-diuretic sesigaba se-thiazide.

Ku-Vitro

IHydrochlorothiazide ingeyesigaba se-thiazide se-diuretics.Yehlisa umthamo wegazi ngokusebenza ezinso ukunciphisa ukumuncwa kabusha kwe-sodium (Na) ku-distal convoluted tubule.Indawo enkulu yesenzo ku-nephron ibonakala ku-electroneutral Na+-Cl co-transporter ngokuqhudelana nendawo ye-chloride kumthuthi.Ngokonakalisa ezokuthutha ze-Na ku-distal convoluted tubule, i-hydrochlorothiazide idala i-natriuresis kanye nokulahlekelwa kwamanzi okuhambisanayo.Ama-Thiazide akhuphula ukumuncwa kabusha kwe-calcium kule ngxenye ngendlela engahlobene nokuthuthwa kwe-sodium.Ukwengeza, ngezinye izindlela, i-Hydrochlorothiazide kukholakala ukuthi yehlisa ukumelana ne-peripheral vascular.

I-Hydrochlorothiazide (i-HCTZ; i-oral bygavage; 12.5 mg/kg/d; amaviki angu-8) ithuthukise ukusebenza kwenhliziyo, yanciphisa inhliziyo ye-interstitial fibrosis kanye nengxenye yevolumu ye-collagen, yehla ukubonakaliswa kwe-AT1, TGF-β kanye ne-Smad2 ezicutshini zenhliziyo kumagundane abesilisa abadala ase-Sprague Dawley.Ngaphezu kwalokho, i-hydrochlorothiazide yehlisa i-plasma angiotensin II namazinga e-aldosterone.Ngaphezu kwalokho, i-hydrochlorothiazide ivimbela i-angiotensin II-induced TGF-.β1 kanye ne-Smad2 protein expression in the neonatal rat ventricular fibroblasts.

Isakhiwo samakhemikhali

Hydrochlorothiazide

ISItifiketi

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

UKUPHATHWA KWEKHWALITHI

Quality management1

Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Quality management2

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Quality management3

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Quality management4

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.

UKUPHATHWA KOMKHIQIZO

cpf5
cpf6

I-Korea Countec Bottled Packaging Line

cpf7
cpf8

I-Taiwan CVC Bottled Packaging Line

cpf9
cpf10

I-Italy CAM Board Packaging Line

cpf11

Umshini Wokuhlanganisa we-Fette waseJalimane

cpf12

I-Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UZAkwethu

Ukubambisana kwamazwe ngamazwe
International cooperation
Ukubambisana kwasekhaya
Domestic cooperation

  • Okwedlule:
  • Olandelayo:

  • Bhala umlayezo wakho lapha futhi usithumelele wona

    Izigaba zemikhiqizo